Medications to Manage Vomiting on Zepbound (tirzepatide): First-Line and Beyond

How often and when does vomiting happen?

In two pooled weight-management trials, adults were treated for up to 72 weeks: 958 on placebo, 630 on 5 mg, 948 on 10 mg and 941 on 15 mg [1]. Vomiting was reported by 2% on placebo, 8% at 5 mg, 11% at 10 mg and 13% at 15 mg [1]. Severe gastrointestinal reactions occurred in 1.7%, 2.5% and 3.1% versus 1% [1]; treatment was stopped for a gastrointestinal reaction by 1.9%, 3.3% and 4.3% versus 0.5% [1]. The label says the majority of nausea, vomiting and diarrhea events occurred during dose escalation and decreased over time [1]. Tirzepatide slows gastric emptying [1].

Is there a first-line antiemetic?

The Zepbound label names no antiemetic, including ondansetron. It notes that Zepbound delays gastric emptying and can affect absorption of oral medicines, and says to monitor drugs dependent on threshold concentrations or with a narrow therapeutic index, naming warfarin [1].

What does the label describe instead?

Zepbound's labeled schedule begins with 2.5 mg once weekly for 4 weeks, followed by 5 mg. Later increases are in 2.5 mg steps after at least 4 weeks at the current dose [1]. The 2.5 mg dose is for initiation, not maintenance [1]. Labeled maintenance is 5, 10 or 15 mg weekly for weight reduction and 10 or 15 mg for obstructive sleep apnea, maximum 15 mg [1]. If a maintenance dose is not tolerated, the label says to consider a lower maintenance dose [1].

What warning signs does the label describe?

The label describes postmarketing acute kidney injury, sometimes requiring hemodialysis, with the majority of reported events in patients whose nausea, vomiting or diarrhea led to dehydration. It calls for renal-function monitoring when a patient reports side effects that could cause dehydration, especially when starting Zepbound or increasing the dose [1]. It describes pancreatitis warning signs as persistent or severe abdominal pain, sometimes radiating to the back, which may or may not include nausea or vomiting, and says to discontinue Zepbound if pancreatitis is suspected [1]. Zepbound is not recommended in severe gastroparesis [1].